article thumbnail

Drug pricing and the 2024 presidential election

Fierce Pharma

As the 2024 U.S. This week on "The Top Line," we explore how each presidential candidate’s approach to drug pricing could shape future policy.

209
209
article thumbnail

CDMO Samsung Biologics bags $1.2B production contract, bringing total 2024 deal value to $3.3B+

Fierce Pharma

With multiple high-profile production pacts already in the books for 2024, CDMO Samsung Biologics has hooked another big one. Following a string of high-profile deals, Samsung Biologics has locked down a $1.2 billion contract with an unnamed Asia-based pharmaceutical company that’s expected to run through December 2037.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pfizer tacks on $1B to 2024 revenue outlook amid cost-cutting drive

Fierce Pharma

For the first time since its sales peaked during the pandemic, Pfizer registered year-over-year revenue growth during the second quarter of 2024. For more than a year after Pfizer’s COVID product sales peaked at the end of 2022, the company’s quarterly revenues showed year-over-year declines. |

Sales 281
article thumbnail

ESC 2024: UK's George Medicines posts positive results for triple-combo blood pressure drug on heels of FDA submission

Fierce Pharma

ESC 2024: UK's George Medicines posts positive results for triple-combo blood pressure drug on heels of FDA submission fkansteiner Fri, 08/30/2024 - 15:54

Medicine 234
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

📆 November 21, 2024 at 11:00 AM PST, 2:00 PM EST, 7:00 PM GMT

article thumbnail

AstraZeneca CEO's 2024 pay proposal under fire from influential proxy advisers

Fierce Pharma

The two most influential proxy advisory firms are rallying investors to vote against the 2024 pay proposal for Soriot at the company’s annual general meeting this month. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again. Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again.

290
290
article thumbnail

WuXi Biologics stays the course with positive 2024 outlook as national security crackdown threatens business in US

Fierce Pharma

WuXi Biologics stays the course with positive 2024 outlook as national security crackdown threatens business in US fkansteiner Wed, 03/27/2024 - 13:12

261
261